medix®

medix®

Empresa mexicana, orientada a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos.

Founded 1940 Mexico

Mexico 448 employees Private Equity Total: $32.00M Biotechnology, Health Care +1

Since it was founded in 1940, medix® has become a leading Mexican company focusing on Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan "Empresa mexicana, orientada a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos" translates to "Mexican company, focused on the research, development, manufacturing, and commercialization of pharmaceutical products". medix® is renowned for its expertise in treating overweight and obesity, backed not only by years of clinical experience but also by its commitment to finding comprehensive solutions. The company is dedicated to addressing the needs of its clients and contributing to reducing the impact of these conditions, ultimately benefiting the population's health. Notably, WAMEX Private Equity made a significant $32.00M Private Equity Round investment in medix® on 31 January 2013. As medix® continues its commitment to constant evolution to offer comprehensive solutions for the benefit of society, it also emphasizes its commitment to environmental and community welfare through sustainable processes and operations. Overall, medix® stands out as a prominent player in the Mexican pharmaceutical industry, with a strong focus on innovative solutions and societal well-being.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	$32.00M	1	WAMEX Private Equity	31 Jan 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

$32.00M

WAMEX Private Equity

31 Jan 2013

FAQ About medix®

Empresa mexicana, orientada a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos.

medix® was founded in 1940.

medix® is headquartered in Mexico.

medix® operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceuticals, obesity treatment, Mexican company and medical solutions.

medix® has approximately 448 employees.

medix® has completed 1 funding round, raising a total of $32.00M. The latest funding stage is Private Equity.

Top alternatives and competitors to medix® include Grupo SOMAR, IMMUNITOR Ltd., Elixir Pharmaceuticals, Tongee Medical Technology, Lipidio Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

medix® and Grupo SOMAR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About medix®

Funding Rounds & Investors (1)

medix® Alternatives & Competitors

FAQ About medix®